Treace Medical Concepts Inc (NAS:TMCI)
$ 8.55 -0.23 (-2.62%) Market Cap: 532.64 Mil Enterprise Value: 534.29 Mil PE Ratio: 0 PB Ratio: 5.06 GF Score: 40/100

Treace Medical Concepts Inc To Host Surgeon Advisor Event Call Transcript

Sep 20, 2022 / 01:00PM GMT
Release Date Price: $23.55 (+2.66%)
John T. Treace
Treace Medical Concepts, Inc. - CEO, Founder & Director

Hello, everybody. Good morning. Thanks for joining us today at our Treace Medical Advisor Event. It's the only company in the med tech industry solely focused on the surgical management of bunions and bunion-related pathologies. It's pretty exciting to have the opportunity to get together like this and take a deeper dive into the unique technologies and clinical data sets that are driving the rapid growth of our business.

We hope today's program will allow you to gain an even better understanding of our disruptive Lapiplasty procedure. As well as the ALIGN3D clinical study and other clinical study data sets we have supporting it. We also hope to provide you a better understanding of the Adductoplasty procedure. The clinical pathology it's targeting, how it interrelates with Lapiplasty and the impact it's making with doctors and their patients.

Finally, we'd like to give you an early preview of some of the newest exciting technologies, those that will continue to drive our growth and differentiation of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot